Leigh Vosseller - Sep 15, 2021 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role
EVP & CHIEF FINANCIAL OFFICER
Signature
s/ David B. Berger, Attorney-in-Fact for Leigh A. Vosseller
Stock symbol
TNDM
Transactions as of
Sep 15, 2021
Transactions value $
-$872,800
Form type
4
Date filed
9/17/2021, 05:21 PM
Previous filing
Sep 15, 2021
Next filing
Oct 14, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNDM Common Stock Options Exercise $66K +3.5K +56.96% $18.86 9.65K Sep 15, 2021 Direct F1
transaction TNDM Common Stock Sale -$438K -3.5K -36.29% $125.00 6.15K Sep 15, 2021 Direct F2
transaction TNDM Common Stock Options Exercise $123K +6.5K +105.78% $18.86 12.6K Sep 16, 2021 Direct F1
transaction TNDM Common Stock Sale -$813K -6.5K -51.4% $125.00 6.15K Sep 16, 2021 Direct F2
holding TNDM Common Stock 145 Sep 15, 2021 Leigh A. Vosseller Trust F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNDM Stock Option Options Exercise $66K +3.5K +7.27% $18.86 51.7K Sep 15, 2021 Common Stock 3.5K $18.86 Direct F4, F5
transaction TNDM Stock Option Options Exercise $123K +6.5K +16.81% $18.86 45.2K Sep 16, 2021 Common Stock 6.5K $18.86 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock received upon exercise of a stock option award.
F2 The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 12, 2021.
F3 The securities are held by the Leigh A. Vosseller Trust dated January 17, 2010, of which Leigh Vosseller is the Trustee.
F4 The options vested as to fifty (50%) of the underlying shares on 6/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").
F5 The expiration date for these options is 10 years from the date of grant.